阿仑单抗(Alemtuzumab)是一种人源化的针对CD52抗原的单克隆抗体。CD52在正常T淋巴细胞、正常B淋巴细胞和恶性淋巴细胞中呈高表达,却不表达于造血干细胞...
基于348个网页-相关网页
RESULTS. : Biopsy-proven glomerular disease recurrence was similar in patients induced with alemtuzumab or IL-2 receptor antagonists.
结果:在用阿仑单抗治疗或白细胞介素-2受体拮抗剂治疗患者中的活组织检查出肾小球疾病复发率相似。
Starting about a week before the transplant, the patients also received a drug called alemtuzumab which destroyed circulating native white blood cells so they couldn't attack the transplanted cells.
移植前一周,患者授受一种称为阿仑单抗的药。该药破坏循环中的自然白细胞,使之丧失攻击移植细胞能力。
应用推荐